Antibodies specific for CD3 and uses thereof
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
06.09.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein. |
|---|---|
| AbstractList | The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein. |
| Author | Tchistiakova, Lioudmila Gennadievna Apgar, James Reasoner Mathur, Divya Katragadda, Madan Jin, Fang |
| Author_xml | – fullname: Katragadda, Madan – fullname: Mathur, Divya – fullname: Tchistiakova, Lioudmila Gennadievna – fullname: Apgar, James Reasoner – fullname: Jin, Fang |
| BookMark | eNrjYmDJy89L5WTQccwryUzKT8lMLVYoLkhNzkzLTFZIyy9ScHYxVkjMS1EoLQbKlGSkFqXmp_EwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkvjQYENDE2MTI0sjJyNjYtQAADVMKuI |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US11434292B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US11434292B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Nov 01 05:39:07 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US11434292B23 |
| Notes | Application Number: US201916417859 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220906&DB=EPODOC&CC=US&NR=11434292B2 |
| ParticipantIDs | epo_espacenet_US11434292B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20220906 |
| PublicationDateYYYYMMDD | 2022-09-06 |
| PublicationDate_xml | – month: 09 year: 2022 text: 20220906 day: 06 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | Pfizer Inc |
| RelatedCompanies_xml | – name: Pfizer Inc |
| Score | 3.417756 |
| Snippet | The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Antibodies specific for CD3 and uses thereof |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220906&DB=EPODOC&locale=&CC=US&NR=11434292B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVdH6YAXJyWCSbV6HIOZFEfrANtJbySYbaA9JMSn-fWeX1HrR27ID-xj4Zr7ZndkFeEwNhrTV1FTu6BigoENSnYJS1SoK18ioVZjyKmY0tobJ4G1hLjqw3tXCyHdCv-TjiIioDPHeSHu92R9ihTK3sn5mK-yqXuK5FyptdGwYmqtZSuh70XQSTgIlCLxkpozfPaT9VPzM5KO5PkAabQs0RB--qErZ_HYp8SkcTnG0sjmDDi97cBzsfl7rwdGovfDGZou9-hyeXstmxSqR9UdEfaTI8SFIOUkQUpKWOdnWKBF8jlfFBTzE0TwYqjjt8mePy2S2XyG9hC7G_vwKiJ2ZFrd1rhcGRkJ55qaM24PMYS6CJ9fta-j_PU7_P-ENnAh9yXQp6xa6zeeW36F_bdi9VMw3cd19SA |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2LrK4LkZDCP5nUIYvMgapsWm0hvIY8N1ENSTIp_39kltV70tuzAPga-mW92Z3YB7hI5RdqqigIxJAxQ0CEJRqEoglYUppwpWqGyq5hpoPnR6GWpLjvwsa2FYe-EfrHHERFRGeK9YfZ6vTvEclhuZf2QrrCrevRCy-Hb6FiWRVPUeGdsufOZM7N527aiBR-8WUj7Ffoz0xjN9R5SbJ2iwX0f06qU9W-X4h3B_hxHK5tj6JCyDz17-_NaHw6m7YU3Nlvs1Sdw_1Q2q7SiWX8crY-kOT4cUk7OdhQuKXNuU6OE8jlSFadw67mh7Qs4bfyzxzha7FaonEEXY39yDpyeqRrRJSIVMkZCeWYmKdFHmZGaCJ5c0gcw_Huc4X_CG-j54XQST56D1ws4pLpjqVPaJXSbzw25Ql_bpNdMSd98yoA7 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Antibodies+specific+for+CD3+and+uses+thereof&rft.inventor=Katragadda%2C+Madan&rft.inventor=Mathur%2C+Divya&rft.inventor=Tchistiakova%2C+Lioudmila+Gennadievna&rft.inventor=Apgar%2C+James+Reasoner&rft.inventor=Jin%2C+Fang&rft.date=2022-09-06&rft.externalDBID=B2&rft.externalDocID=US11434292B2 |